Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 21.
doi: 10.1111/all.70109. Online ahead of print.

High Serum TSLP Is Characteristic of Late-Onset, Long-Duration, Eosinophilic Asthma

Maho Suzukawa  1 , Ken Ohta  1   2 , Hiroyuki Tashimo  1 , Osamu Narumoto  1 , Hiroya Hashimoto  3   4 , Toshiyuki Kita  5 , Hazuki Takato  5 , Hiroyuki Nagase  6 , Konomi Kobayashi  6 , Masao Yamaguchi  6 , Masahiro Abe  7 , Ryoji Ito  7 , Takeo Endo  8 , Hidetoshi Yanai  8 , Kenji Chibana  9 , Nobuyuki Hizawa  10 , Yasushi Tanimoto  11 , Koichi Takagi  12 , Tsuyoshi Oguma  13 , Norihiro Harada  14 , Hironori Sagara  15 , Aika Kato  16   17 , Shohei Takata  18 , Yuko Komase  19 , Kentaro Hyodo  20 , Kazuto Matsunaga  21 , Kazuyuki Tsujino  22 , Akio Niimi  23 , Kentaro Wakamatsu  24 , Hisatoshi Sugiura  25 , Yumi Sakakibara  26 , Mitsuhiro Kamimura  27 , Yoko Shibata  28 , Goh Tanaka  29 , Keitaro Nakamoto  30 , Shinji Tamaki  31 , Yoshiaki Minakata  32 , Takanori Numata  33 , Akiko M Saito  3 , Nobuyuki Kobayashi  1   34 , Masami Taniguchi  35 ; TNH‐Azma Research Group (TARG)
Collaborators, Affiliations

High Serum TSLP Is Characteristic of Late-Onset, Long-Duration, Eosinophilic Asthma

Maho Suzukawa et al. Allergy. .

Abstract

Background: Thymic stromal lymphopoietin (TSLP) is a master regulator of type 2 immune responses; however, the associations between serum TSLP and the characteristics of adult asthma have not been fully clarified. The aim of this study was to determine the characteristics of adult asthma with high serum TSLP and explore TSLP's association with the late-onset eosinophilic asthma phenotype.

Methods: Baseline data of the TNH-Azma study (a real-world observational cohort study conducted in Japan on 1344 patients with asthma from 30 hospitals) was used and serum cytokines were measured. Patients were stratified into quartile groups based on the baseline serum TSLP levels, and their clinical characteristics were compared. Multivariable regression analyses were used to determine clinical variables associated with serum TSLP and cytokines associated with the late-onset eosinophilic asthma phenotype.

Results: Patients with TSLP-high asthma were older, late-onset, eosinophilic, and less atopic; had a higher BMI; more smoking history; and more asthma-COPD overlap, sleep apnea syndrome (SAS), hypertension, and heart disease. They also exhibited lower lung function with worse asthma symptoms and were more frequently on oral corticosteroids. Multivariable regression analyses adjusted for age and sex demonstrated that a high TSLP level was positively associated with later asthma onset, longer asthma duration, hypertension, higher blood eosinophils, BMI, smoking history, use of biologics, SAS, and high Fres, and was negatively associated with pollinosis. Among the serum cytokines, TSLP exhibited the strongest association with late-onset, eosinophilic asthma.

Conclusion: High serum TSLP is a distinctive feature of late-onset, long-duration, eosinophilic asthma. Patients with asthma with this feature may be a unique target population for specific asthma therapy.

Keywords: asthma; cytokine; eosinophils; phenotype; thymic stromal lymphopoietin (TSLP).

PubMed Disclaimer

References

    1. M. Suzukawa, K. Ohta, Y. Fukutomi, et al., “Classifications of Moderate to Severe Asthma Phenotypes in Japan and Analysis of Serum Biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study),” Allergology International 72, no. 1 (2023): 63–74.
    1. P. Haldar, I. D. Pavord, D. E. Shaw, et al., “Cluster Analysis and Clinical Asthma Phenotypes,” American Journal of Respiratory and Critical Care Medicine 178, no. 3 (2008): 218–224.
    1. W. C. Moore, E. R. Bleecker, D. Curran‐Everett, et al., “Characterization of the Severe Asthma Phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program,” Journal of Allergy and Clinical Immunology 119, no. 2 (2007): 405–413.
    1. M. Schatz, J. W. Hsu, R. S. Zeiger, et al., “Phenotypes Determined by Cluster Analysis in Severe or Difficult‐to‐Treat Asthma,” Journal of Allergy and Clinical Immunology 133, no. 6 (2014): 1549–1556.
    1. S. E. Wenzel, “Asthma Phenotypes: The Evolution From Clinical to Molecular Approaches,” Nature Medicine 18, no. 5 (2012): 716–725.

Grants and funding

LinkOut - more resources